Organigram Global Appoints James Yamanaka as Chief Executive

Dow Jones11-25
 

By Adriano Marchese

 

Organigram Global has appointed James Yamanaka as its new chief executive officer, effective mid-January.

Yamanaka joins the Canadian cannabis producer from British American Tobacco where he served for over 20 years, most recently as global head of strategy.

In particular, Organigram said that Yamanaka brings with him extensive experience in strategy and general management across Europe and Asia.

He is set to begin on or around Jan. 15, and until then, board chairman, Peter Amirault, has been appointed to serve as executive chair on an interim basis effective Dec.1, to oversee day-to-day management of the company until Yamanaka is fully brought on board.

 

Write to Adriano Marchese at adriano.marchese@wsj.com

 

(END) Dow Jones Newswires

November 25, 2025 06:15 ET (11:15 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment